back to open calls
Opens:
27/7/2020
Closes:
7/10/2020
Sectors:
All
Health & Life Sciences
Project Size:
TBC

Summary

UK registered organisations can apply for a share of up to £30 million to develop innovative healthcare products, technologies, and processes.


These can include, for example:

  • Disease prevention and proactive management of health and chronic conditions
  • Earlier and better detection and diagnosis of disease, leading to better patient outcomes
  • Tailored treatments that either change the underlying disease or offer potential cures


Eligibility

Your project must:

  • Have total eligible costs between £250,000 and £4 million
  • Start on 1 March 2021
  • End by 29 February 2024
  • Last between 12 months and 36 months


To lead a project or work alone your organisation must:

  • Be a UK registered micro, small or medium-sized enterprise SME or a research and technology organisation (RTO)
  • Carry out its project work in the UK
  • Intend to exploit the results from or in the UK


If the lead organisation is an RTO you must collaborate with at least one SME.


Your project can include partners that do not receive any of this competition’s funding, for example non-UK businesses or large businesses. Their costs will count towards the total eligible project costs. Subcontractors are allowed in this competition. Subcontractors can be from anywhere in the UK.


Scope

The aim of this early and late stage competition is to enable companies to create a data package that can support the subsequent testing of their products, or to carry out evaluations in a clinical setting or other relevant environment.


Testing can include:

  • Experimental evaluation (at laboratory scale)
  • Use of in vitro and in vivo models to evaluate proof of concept or safety
  • Exploring potential production mechanisms
  • Prototyping
  • Product development planning
  • Intellectual property protection
  • Demonstrating of clinical utility and effectiveness
  • Demonstrating of safety and efficacy (including phase 1 and 2 clinical trials)
  • Regulatory planning


Early stage: The aim of an early-stage award is to create a data package that is sufficient to support the testing of your product or process in a clinical setting or other relevant environment.


Late stage: The late-stage award is designed to test a well-developed concept and show its effectiveness in a clinical setting or other relevant environment.


Particularly welcome applications that support innovation in the following areas:

  • Child health technologies
  • Innovations that support clinical trials in the UK
  • Biomedical innovations that combat the threat of antimicrobial resistance


Interested in this call? Book a free consultation with our team
Book a Consultation
+44 (0) 1925 506 100
Contact Us
Thank you! We will be in touch shortly.
Oops! Something went wrong while submitting the form.